Prompt and Model
Safety & society

Isomorphic Labs' $5B funding leads European AI investment surge

Isomorphic Labs secured a $5 billion Series C round, the largest deal in a week where European tech funding hit €6 billion across 65 deals.

Isomorphic Labs secured a $5 billion Series C round, the largest deal in a week where European tech funding hit €6...

European tech funding reached €6 billion this week across 65 deals, with AI-driven biotech firm Isomorphic Labs securing a landmark $5 billion investment. The activity shows a surging investment landscape where AI is the dominant theme, from major financings to strategic acquisitions and policy debates.

Goldman Sachs led a $280 million funding round in fintech firm Payhawk. In neurotech, Swiss company Indivi acquired Cogitat to advance AI-powered brain monitoring. Green Mobility Holding is acquiring Deutsche Dienstrad. Venture firm Plural doubled its fund to €1 billion to back frontier founders, while adesso Ventures secured €26 million for its second fund. Visage Technologies launched a €3.1 million EU-backed project for adaptive training tech. Overall investment in European startups has surged to $81 billion according to recent data.

Isomorphic Labs' $5 billion breakthrough

Isomorphic Labs secured a $5 billion Series C funding round, the largest deal tracked this week. The round was co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz joining as a new investor. Bloomberg reported the company was seeking funding at a $50 billion valuation.

Founded in 2021 as a spinout from Google DeepMind and led by CEO Demis Hassabis, the company uses its AI platform, IsoDDE, to model biological systems and design drug candidates. It has established partnerships with pharmaceutical giants Eli Lilly, Novartis, and Johnson & Johnson. The new capital will be used to expand its drug-design engine, develop more advanced biological simulation models, and build clinical infrastructure.

The company previously raised $2.1 billion in a Series B round in March 2025, bringing its total funding to $7.7 billion across three rounds. The $5 billion injection alone equals approximately £3.8 billion, a figure that exceeds the £2.8 billion raised by the entire UK biotech sector in venture capital during the first nine months of 2026.

European AI investment context

AI served as the common thread in funding conversations across the continent, though the focus differed between mature and emerging ecosystems. Discussions in places like Helsinki centered on infrastructure, commercialisation, and technological sovereignty. In smaller hubs like Yerevan, Armenia, the talk was about the opportunities for growing ecosystems.

Despite the momentum, European tech ecosystems universally face challenges in retaining top talent, accessing sufficient capital, commercialising technical expertise, and building companies that achieve international scale. At a recent major tech conference, European tech leaders cited €100 billion in company value while demanding political reforms to bolster the sector.

Other notable AI funding rounds this week included Genesis AI receiving a $500 million investment at a $3.5 billion valuation. Several smaller, specialised AI firms also secured backing:

CompanySectorAmount Raised
Perry AILegal automation$2.2 million
Palm HealthChildren's medical history€1.25 million
NABUFinancial compliance automation€1.1 million
NoahEnterprise AI integration€800,000

Additionally, Wallenberg Investments took a minority stake in simulation software firm Algoryx. The week also saw over four exits and merger and acquisition transactions. Isomorphic Labs now plans to expand its drug-design engine and build clinical infrastructure using its historic $5 billion funding.

Related coverage

More from Safety & society